Ionis Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Good morning, everyone. My name is Jess Fye. I'm one of the biotech analysts at JPMorgan. And we're continuing the 2020 Healthcare Conference this morning with Ionis. We're going to host a Q&A session with the management team right after this. It's just down the hall in the Olympic room. You can follow me down there if you're interested.
But for the presentation, I'm going to turn it over to the company's CEO, Brett Monia.
Good morning, everybody, and thank you for coming so early to this presentation. And thanks, Jess, for the introduction.
These are my forward-looking statements. I recommend them to you to review at your convenience.
These are indeed new days at Ionis Pharmaceuticals as I, Brett Monia, take on a new role at Ionis as the Chief Executive Officer, as Jess mentioned. It's a role that I'm incredibly excited about and very much looking forward to. And I'm confident
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |